Trademark Overview
On Thursday, October 9, 2025, a trademark application was filed for PANTHER with the United States Patent and Trademark Office. The USPTO has given the PANTHER trademark a serial number of 99434165. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 9, 2025. This trademark is owned by PanTher Therapeutics, Inc.. The PANTHER trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical products in the nature of implantable solid drug formulations for the treatment of cancer; Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate delivery of pharmaceuticals for the prevention, diagnosis, and treatment of cancer; Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate localized delivery of pharmaceuticals for the sustained treatment of cancer; Pharmaceutical products in the nature of implantable solid drug formulations that improve therapeutic efficacy, minimize systemic toxicity, and expand treatment options, all related to cancer
Implantable solid drug formulations to treat cancer; Drug delivery system in the nature of a system that delivers an implantable solid drug formulation to treat cancer; Drug delivery system in the nature of a system to prevent, diagnose, and treat cancer; Drug delivery system that facilitates delivery of pharmaceuticals that improve therapeutic efficacy, minimize systemic toxicity, and expand treatment options, all related to cancer
